Progressive Multifocal Leukoencephalopathy in a Young Medication-Noncompliant HIV Patient: A Case Report and Literature Review
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Progressive multifocal leukoencephalopathy (PML) is a rare and debilitating opportunistic infection of the central nervous system (CNS) caused by the John Cunningham (JC) virus. It predominantly affects immunocompromised individuals, including those with advanced HIV infection. The incidence of PML in people living with human immunodeficiency virus (HIV) has significantly declined in the era of antiretroviral therapy (ART). We report a case of PML in a young patient with a history of medication non-compliance, presenting with progressive neurological deficits, underscoring the importance of adherence to ART in preventing opportunistic infections.
References
1.
Nshimiyimana J, Onsongo S
. Progressive Multifocal Leukoencephalopathy confined to the posterior fossa as the presenting manifestation of HIV in a paediatric patient. IDCases. 2024; 37:e02064.
PMC: 11388200.
DOI: 10.1016/j.idcr.2024.e02064.
View
2.
Jiang R, Song Z, Liu L, Mei X, Sun J, Qi T
. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era. Front Cell Infect Microbiol. 2023; 13:1208155.
PMC: 10663249.
DOI: 10.3389/fcimb.2023.1208155.
View
3.
Engsig F, Hansen A, Omland L, Kronborg G, Gerstoft J, Lund Laursen A
. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2008; 199(1):77-83.
DOI: 10.1086/595299.
View
4.
Tan C, Koralnik I
. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010; 9(4):425-37.
PMC: 2880524.
DOI: 10.1016/S1474-4422(10)70040-5.
View
5.
Khalili A, Craigie M, Donadoni M, Sariyer I
. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML). J Neuroimmune Pharmacol. 2019; 14(4):649-660.
PMC: 6898772.
DOI: 10.1007/s11481-019-09877-8.
View